COVID-19 vaccine counseling and safety assessment in children and teenagers with underlying medical conditions in China: a single center study
暂无分享,去创建一个
Xiangshi Wang | M. Zeng | Hailing Chang | Y. Ge | X. Zhai | Yanfeng Zhu | Wenjie Ma | Tianxing Feng
[1] M. Ardura,et al. An Exploration of COVID-19 Impact and Vaccine Hesitancy in Parents of Pediatric Hematopoietic Stem Cell Transplant (HCT) Recipients , 2022, Bone Marrow Transplantation.
[2] Wei Peng,et al. COVID‐19 vaccine take‐up rate and safety in adults with epilepsy: Data from a multicenter study in China , 2021, Epilepsia.
[3] Weihong Lin,et al. A Survey of Hesitancy and Response to the COVID-19 Vaccine Among Patients With Epilepsy in Northeast China , 2021, Frontiers in Neurology.
[4] C. Agostoni,et al. COVID-19 Vaccine Hesitancy among Parents of Children and Adolescents Living in Brazil , 2021, Vaccines.
[5] Matthew M Davis,et al. Parental COVID-19 vaccine hesitancy for children: vulnerability in an urban hotspot , 2021, BMC Public Health.
[6] J. Nelson,et al. Surveillance for Adverse Events After COVID-19 mRNA Vaccination. , 2021, JAMA.
[7] W. Wang,et al. Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial , 2021, The Lancet Infectious Diseases.
[8] H. Oshitani,et al. Roles of Children and Adolescents in COVID-19 Transmission in the Community: A Retrospective Analysis of Nationwide Data in Japan , 2021, Frontiers in Pediatrics.
[9] S. Ahmad,et al. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study , 2021, Seizure.
[10] Changgui Li,et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial , 2021, The Lancet Infectious Diseases.
[11] A. Sahraian,et al. Physicians’ opinions on the necessity of COVID‐19 vaccination in patients with epilepsy , 2021, Epileptic disorders : international epilepsy journal with videotape.
[12] Austin Waters,et al. COVID-19 Vaccine Hesitancy Among Adolescent and Young Adult Cancer Survivors , 2021, JNCI cancer spectrum.
[13] K. Hoffman,et al. COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey , 2021, JMIR public health and surveillance.
[14] S. Vieths,et al. EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines , 2021, Allergy.
[15] E. Şenel,et al. Evaluation of COVID-19 Vaccine Refusal in Parents. , 2021, The Pediatric infectious disease journal.
[16] A. Sheikh,et al. Vaccination and allergy: EAACI position paper, practical aspects , 2017, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[17] P. Demoly,et al. International Consensus (ICON): allergic reactions to vaccines , 2016, The World Allergy Organization journal.
[18] Nicola P Klein,et al. Risk of anaphylaxis after vaccination in children and adults. , 2016, The Journal of allergy and clinical immunology.
[19] V. Usonis,et al. Immunization of high-risk paediatric populations: Central European Vaccination Awareness Group recommendations , 2014, Expert review of vaccines.